Literature DB >> 12399548

Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

Swee Kee Wong1, David W Lazinski.   

Abstract

Hepatitis delta virus (HDV) uses a host-encoded RNA-editing activity to express its two essential proteins from the same coding sequence. Adenosine deaminase that acts on RNA (ADAR)1 and ADAR2 are enzymes that catalyze such reactions, and each, when overexpressed, are capable of editing HDV RNA in vivo. However, the enzyme responsible for editing HDV RNA during replication has not been determined. Mammalian cells express two forms of ADAR1, a large form (ADAR1-L) that mainly localizes to the cytoplasm and a small form (ADAR1-S) that resides in the nucleus. Recently, we found that the specific activity of ADAR1-L within cells is much higher than that of ADAR1-S but only when the substrate can be edited in the cytoplasm. Here we observed that although both ADAR1-S and ADAR1-L were expressed throughout HDV replication, no ADAR2 could be observed at any time. Using expression vectors that individually overexpress either form of ADAR1, we found that ADAR1-S could stimulate editing during replication more efficiently. We next reduced ADAR1 levels during HDV replication. After transfection of an ADAR1-L-specific small interfering RNA (siRNA), we observed a significant loss of that protein and its associated cytoplasmic editing activity while the level of ADAR1-S remained unchanged. Transfection of this siRNA, however, did not reduce editing during HDV replication. In contrast, transfection of an siRNA that targets both forms of ADAR1 greatly reduced the expression of both proteins and potently inhibited editing during replication. We conclude that ADAR1-S edits HDV RNA during replication and that editing occurs in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12399548      PMCID: PMC137553          DOI: 10.1073/pnas.232416799

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells.

Authors:  S M Hammond; E Bernstein; D Beach; G J Hannon
Journal:  Nature       Date:  2000-03-16       Impact factor: 49.962

2.  Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.

Authors:  M Higuchi; S Maas; F N Single; J Hartner; A Rozov; N Burnashev; D Feldmeyer; R Sprengel; P H Seeburg
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

3.  Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences.

Authors:  J Chang; L J Sigal; A Lerro; J Taylor
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

5.  Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.

Authors:  S Sato; S K Wong; D W Lazinski
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter.

Authors:  K Kawakubo; C E Samuel
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

7.  Substrate recognition by ADAR1 and ADAR2.

Authors:  S K Wong; S Sato; D W Lazinski
Journal:  RNA       Date:  2001-06       Impact factor: 4.942

8.  CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.

Authors:  H Poulsen; J Nilsson; C K Damgaard; J Egebjerg; J Kjems
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

9.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase.

Authors:  J B Patterson; C E Samuel
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

10.  Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA.

Authors:  J L Casey; J L Gerin
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  65 in total

1.  Elevated activity of the large form of ADAR1 in vivo: very efficient RNA editing occurs in the cytoplasm.

Authors:  Swee Kee Wong; Shuji Sato; David W Lazinski
Journal:  RNA       Date:  2003-05       Impact factor: 4.942

2.  By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression.

Authors:  Shuji Sato; Cromwell Cornillez-Ty; David W Lazinski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 3.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

Review 4.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 5.  RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

Authors:  Michael M C Lai
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  The role of a metastable RNA secondary structure in hepatitis delta virus genotype III RNA editing.

Authors:  Sarah D Linnstaedt; Wojciech K Kasprzak; Bruce A Shapiro; John L Casey
Journal:  RNA       Date:  2006-06-21       Impact factor: 4.942

7.  The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.

Authors:  Ji-Young Min; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

Review 8.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

9.  Effects of conserved RNA secondary structures on hepatitis delta virus genotype I RNA editing, replication, and virus production.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.